Physical Therapy Central Of Jones | |
12950 E Britton Rd, Jones, OK 73049-7400 | |
(405) 809-8650 | |
(405) 399-5512 |
Full Name | Physical Therapy Central Of Jones |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 12950 E Britton Rd, Jones, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164852612 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Physical Therapy Central Of Jones 440 Merchant Dr, Norman, OK 73069-6470 Ph: (405) 579-1600 | Physical Therapy Central Of Jones 12950 E Britton Rd, Jones, OK 73049-7400 Ph: (405) 809-8650 |
News Archive
Belmont Village Senior Living will officially open its 20th community in August 2011 at 3680 N. Moorpark Road in Thousand Oaks. The company has opened an on-site Information Center to provide details about leasing and the care and amenities that will be available for residents.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).
A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib-the only approved ALK inhibitor. Results of this Novartis-sponsored sudy will be presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology on Sunday, June 3.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
50,000 people or 10% of the 500,000 people in the U.S with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery for coverage of life saving drugs.
› Verified 2 days ago
Eagles Nest Pediatric Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 14700 Sharon Springs Dr, Jones, OK 73049 Phone: 405-623-9178 | |
Julia Wilson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15000 N Douglas Blvd, Jones, OK 73049 Phone: 405-396-4774 Fax: 405-396-4774 |